Barbara Boyan, PhD, dean of Richmond-based Virginia Commonwealth University’s School of Engineering, will answer this question during a Titan Spine-sponsored webinar. The biomaterial science expert will explain how biochemical processes spur early-stage bone growth as well as dive into the affect of material and topographies at the micro and nano levels on osteoblastic differentiation of attachment-dependent cells.
Also tune in to hear Paul Slosar, MD, president of San Francisco-based SpineCare Medical Group, expand on clinical outcomes achieved with these nano-enhanced implants.
To register for the webinar on Sept. 28 from 12-1 p.m., click here.
More articles on devices:
GE Healthcare receives FDA clearance for MAGiC MR technique: 5 things to know
NuVasive names Jason Hannon president, COO & Patrick S. Miles vice chairman: 5 key notes
33% of orthopedic surgeons to use robotic systems by 2018: 6 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
